- Home
- FTW vs ORGO Comparison
FTW vs ORGO Comparison
Compare FTW & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTW
- ORGO
- Stock Information
- Founded
- FTW N/A
- ORGO 1985
- Country
- FTW
- ORGO United States
- Employees
- FTW N/A
- ORGO N/A
- Industry
- FTW Oil & Gas Production
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- FTW Energy
- ORGO Health Care
- Exchange
- FTW Nasdaq
- ORGO Nasdaq
- Market Cap
- FTW 465.8M
- ORGO 539.1M
- IPO Year
- FTW 2024
- ORGO N/A
- Fundamental
- Price
- FTW $10.45
- ORGO $5.60
- Analyst Decision
- FTW
- ORGO Buy
- Analyst Count
- FTW 0
- ORGO 3
- Target Price
- FTW N/A
- ORGO $7.33
- AVG Volume (30 Days)
- FTW N/A
- ORGO 2.3M
- Earning Date
- FTW N/A
- ORGO 11-06-2025
- Dividend Yield
- FTW N/A
- ORGO N/A
- EPS Growth
- FTW N/A
- ORGO N/A
- EPS
- FTW N/A
- ORGO N/A
- Revenue
- FTW N/A
- ORGO $465,218,000.00
- Revenue This Year
- FTW N/A
- ORGO $2.51
- Revenue Next Year
- FTW N/A
- ORGO $25.45
- P/E Ratio
- FTW N/A
- ORGO N/A
- Revenue Growth
- FTW N/A
- ORGO 2.24
- 52 Week Low
- FTW N/A
- ORGO $2.61
- 52 Week High
- FTW N/A
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- FTW N/A
- ORGO 77.10
- Support Level
- FTW N/A
- ORGO $3.84
- Resistance Level
- FTW N/A
- ORGO $4.08
- Average True Range (ATR)
- FTW 0.00
- ORGO 0.26
- MACD
- FTW 0.00
- ORGO 0.10
- Stochastic Oscillator
- FTW 0.00
- ORGO 77.54
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.